Rerouting cardiovascular management following gastric bypass surgery: Dose optimization of carvedilol using population-based analysis.

导出原文传递

翻译打印收藏纠错

第一作者： Priscila Akemi,Yamamoto

第一单位： Center for Pharmacometrics and Systems Pharmacology, College of Pharmacy, University of Florida, Orlando, FL, USA.;School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo (USP), Ribeirão Preto, SP, Brazil.

作者： Priscila Akemi,Yamamoto ^[1] ; Valvanera,Vozmediano ^[2] ; Rodrigo,Cristofoletti ^[2] ; Jinmai,Jiang ^[3] ; Thomas D,Schmittgen ^[3] ; Cristiane Masetto,de Gaitani ^[4] ; Rafael,Kemp ^[5] ; Ajith Kumar,Sankarankutty ^[5] ; Jose Sebastião,Dos Santos ^[5] ; Wilson,Salgado Junior ^[5] ; Natalia Valadares,de Moraes ^[2]

作者单位： Center for Pharmacometrics and Systems Pharmacology, College of Pharmacy, University of Florida, Orlando, FL, USA.;School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo (USP), Ribeirão Preto, SP, Brazil. ^[1] Center for Pharmacometrics and Systems Pharmacology, College of Pharmacy, University of Florida, Orlando, FL, USA. ^[2] Cancer Genetics Research Complex, College of Pharmacy, University of Florida, Gainesville, FL, USA. ^[3] School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo (USP), Ribeirão Preto, SP, Brazil. ^[4] School of Medicine of Ribeirão Preto, University of São Paulo (USP), Ribeirão Preto, SP, Brazil. ^[5]

关键词 carvedilol gastric bypass pharmacokinetics population‐based analysis